In the article titled “A Liquid-Based Cytology System, without the Use of Cytocentrifugation, for Detection of Podocytes in Urine Samples of Patients with Diabetic Nephropathy” [1], the authors would like to clarify why the SurePath™ method was used in urine from diabetic nephropathy patients. The following text should be replaced with the addition of two missing references, 26 and 27 [2, 3]:
Original:
A similar technique of liquid-based cytology currently used in the cytodiagnosis of cervical cancer has replaced the conventional Pap smear cytology [25]. Our method using SurePath™ is simple and improved the detection of podocytes in urine samples.
Revised:
A similar technique of liquid-based cytology currently used in the cytodiagnosis of cervical cancer has replaced the conventional Pap smear cytology [25]. Additionally, a similar approach has been used to detect WT-1-positive cells in kidney disease [26], and its application in the diagnosis of kidney disease has also been studied [27]. Our method using SurePath™ is simple and is expected to improve the detection of podocalyxin-positive podocytes in urine samples compared with our conventional method.
References
- 1.Kimura M., Toyoda M., Saito N., et al. A liquid-based cytology system, without the use of cytocentrifugation, for detection of podocytes in urine samples of patients with diabetic nephropathy. Journal of Diabetes Research. 2019;2019:7. doi: 10.1155/2019/9475637.9475637 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ohsaki H., Sofue T., Kawakami K., et al. WT1 immunoenzyme staining using SurePath™ processed urine cytology helps to detect kidney disease. Cytopathology. 2016;27(1):43–49. doi: 10.1111/cyt.12227. [DOI] [PubMed] [Google Scholar]
- 3.Fujita T., Sofue T., Moritoki M., et al. Urinary WT1-positive cells as a non-invasive biomarker of crescent formation. Cytopathology. 2017;28(6):524–530. doi: 10.1111/cyt.12460. [DOI] [PubMed] [Google Scholar]